← Leaderboards
Andrew Kao
University Of Pennsylvania
$273,406
Attributed
$273,406
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$273,406 · 1
By mechanism
M01$273,406 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Thomas R. Kleyman$23,621,197
- Mary Beth Leonard$17,530,683
- Katalin Susztak$23,917,616
- Emma Meagher$1,473,964
- Laura Mariachiara Barisoni$904,065
Others in their field
Top investigators on “Azepines”
- Sherry R Chemler · Sloan-Kettering Institute For Cancer Res$1,683,722
- Tom G Driver · University Of Illinois At Chicago$1,517,611
- Andre Rosowsky · Dana-Farber Cancer Institute$1,492,090
- Larry E. Overman · University Of California Irvine$1,430,777
- Jun O. Liu · Johns Hopkins University$744,574
- Melissa Ramirez · University Of California Los Angeles$490,534
Research focus
AzepinesClinical ResearchClinical Trial Phase ICongestive Heart FailureDiuresisDiureticsDrug Adverse EffectDrug Screening /EvaluationHeart PharmacologyHuman SubjectLiver CirrhosisNephrotic SyndromePharmacokineticsPhenylamideVasopressins
Grant awards (6)
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$124,146
M01 · FY2002 · RR
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$124,146
M01 · FY2001 · RR
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2001 · RR
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$25,114
M01 · FY2000 · RR
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR
PHARMACOLOGY STUDY OF VPA 985 IN PTS W/ CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR